Introduction: Multimodal imaging agent has the potential to overcome the shortage and incorporate the advantages of different imaging tools for extremely sensitive diagnosis. To achieve multimodal imaging, combining multiple contrast agents into a special nanostructure has become a main strategy; However, the combination of all of these functions into one nanoplatform usually requires a complicated synthetic procedure that results in heterogeneous nanostructure. Methods: In this study, we develop ultrasmall gold nanoclusters with 15 gold atoms (Au 15 NCs) functionalized with diethylenetriamine-pentaacetic acid dianhydride (DTPAA-Gd) as an optimized multimodal imaging agent to enhance imaging ability. Results: The Au 15 NCs-DTPAA-Gd nanohybrids possess the ultra-small size and are capable of enhancing the contrast in near-infrared fluorescence (NIRF), magnetic resonance (MR) and X-ray computed tomography (CT) imaging. Meanwhile, the integrated DTPAA-Gd component not only endow the nanohybrids to produce higher T 1 relaxivity (r 1 = 21.4 mM
Introduction
Multimodal imaging nanoplatforms have evoked considerable interest to circumvent the limitations of single imaging modes and incorporate the advantages of different imaging modality.
1,2 A number of imaging techniques are introduced to these platforms for clinical diagnosis. 3, 4 Among the diverse diagnostic techniques, X-ray computed tomography (CT) displays a high degree of spatial resolution of the hard tissues, and magnetic resonance imaging (MRI) is a powerful noninvasive modality with excellent softtissues resolution. 5, 6 MRI and CT are suitable for anatomical reconstruction but have poor sensitivity and lack of molecular details. 7, 8 Near-infrared fluorescence (NIRF)
imaging is suitable for multiscale imaging from the cellular level to whole-body animals. 8, 9 To achieve multifunction with MR, CT, and NIRF imaging, combining different imaging contrast agents into a macromolecule or encapsulation of them into a special nanostructure (e.g., hollow nanosphere or mesoporous nanoparticle) has become a main strategy. [10] [11] [12] [13] However, the magnetic, X-ray attenuation, and fluorescent properties usually originate from different molecules (or moieties), 13 and the combination of all of these functions into one nanoplatform usually not only requires a complicated synthetic procedure but lead to heterogeneous nanostructure. 14 Moreover, the introduction of an additional function is often accompanied by a decrease in the original function. 14 Therefore, it is necessary to explore effective synthetic strategies to fabricate excellent multifunction nanomaterials for multimodal bioimaging. Gold nanoclusters (AuNCs) are intensely investigated as imaging contrast agents, owing to intensive fluorescence, extraordinary photostability, easy synthesis, and excellent biocompatibility. [15] [16] [17] [18] Based on strong quantum confinement effect (SQCE) related to the size of clusters, AuNCs with different sizes may exhibit unique optical properties which extend from the red-spectral region to the biologically important near-infrared (NIR) window. 19, 20 Recently, the composite nanomaterials with AuNCs have been extensively explored in multimodal imaging systems, such as fluorescence/CT, fluorescence/Magnetic resonance imaging (MRI), fluorescence/positron emission tomography (PET). 21, 22 However, complicated synthetic procedure and interactions between different imaging components lead to the decrease and instability of the fluorescence characteristics of AuNCs. Fortunately, gold atoms with high atomic number and electron density possess high X-ray attenuation coefficient. 23, 24 In our previous study, a sub-nanometer ultrasmall AuNCs with 15 gold atoms (Au 15 NCs) may have access to both alluring optical characteristics and remarkable X-ray attenuation properties. 25 Therefore, Au 15 NCs have great potential to be used as multimodal imaging platform to achieve both NIRF and CT imaging ability. In this study, a novel kind of biocompatible and highperforming trimodal contrast agent (Au 15 NCs-DTPAA-Gd) has been elaborately designed through covalently conjugating gadolinium-Diethylenetriamine-pentaacetic acid dianhydride (DTPAA-Gd) to Au 15 NCs. Only by coupling Au 15 NCs with gadolinium chelate, the obtained Au 15 NCs-DTPAA-Gd exhibit dramatically promoted longitudinal relaxivity, near-infrared fluorescence signal and X-ray attenuation properties. It is worth noting that imaging components promote each other, which addresses the limitations of interference between imaging elements of conventional multimodal platforms. The in vivo imaging ability was validated on mice through MR and CT imaging, where Au 15 NCs-DTPAA-Gd produced robust and prolonged contrast enhancement. The in vivo fluorescent imaging was validated on nude mice, where the red light produced by Au 15 NCs-DTPAA-Gd under 485 nm excitation light can effectively penetrate the tissue and be observed by the human eye. The pharmacokinetics and biodistribution studies display appropriately decelerated plasma decay and renal excretion, which would be of great significance in accurate clinical diagnosis. The nanometer platform enables the perfect integration of each component and maximizes the imaging capacity of each component, which has great potential for medical imaging. To the best of our knowledge, this is the first report associated with the synthesis of DTPAA-Gd-functionalized Au 15 NCs for NIRF/CT/MR trimodal imaging applications.
Materials and Methods Materials
All chemicals of analytical grade were used without further purification. Chloroauric acid (HAuCl 4 ·4H 2 O) was purchased from Chemart (Tianjin, China). Reduced glutathione (rGSH, 98%) was obtained from Solarbio (Beijing, China). Diethylenetriamine-pentaacetic acid dianhydride (DTPAA, 95%) was purchased from Alfa Aesar (Shanghai, China). Gadolinium (Ⅲ) chloride (GdCl 3 ·6H 2 O), Dimethyl sulfoxide (DMSO, >99%), and Sodium acetate anhydrous (CH 3 COONa) were purchased from Sigma-Aldrich (St. Louis, USA). 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was purchased from Merck (Germany). The other chemicals were purchased from Sigma-Aldrich (St. Louis, USA). Deionized water used throughout the experiments was acquired from Mili-Q water purification system after its resistivity reached 18.2 MΩ CM.
Human renal epithelial cell line (293T cell line) and human hepatocellular carcinoma cell line (HepG2 cell line) were acquired from Molecular Imaging Lab of Tianjin Medical University (Tianjin, China). The use of these cell lines had Molecular Imaging Lab of Tianjin Medical University review board approval. The female BALB/c mice and BALB/c athymic nude mice were obtained from Beijing Vital River Laboratory Animal Technology Co., Ltd (Beijing, China).
Synthesis of Au 15 NCs-DTPAA-Gd
First, ultrasmall gold nanoclusters with 15 gold atoms (Au 15 NCs) were prepared according to our previous report. 25 The freshly prepared aqueous solutions of HAuCl 4 (24 mM, 4.2 mL) were mixed into a 50-mL glass flask containing 43. 
In vitro CT/NIRF/MR Imaging
The in vitro CT imaging of Au 15 NCs, Au 15 NCs-DTPAA-Gd and Omnipaque was acquired using Light Speed VCT system (General Electric Company, America) with imaging parameters: 120 keV, 80 mA, and a slice thickness of 0.625 mm. Evaluation of the X-ray attenuation intensity was carried out by loading the digital CT images in a standard display program ; echo time (TE), 160 ms; repetition time (TR), 600 ms; slice thickness, 1 mm; spacing, 1.0 mm. The linear fitting of inverse T 1 and T 2 relaxation time (1/T 1 and 1/T 2 ) as a function of Gd concentration (mM) were taken to calculate the T 1 (r 1 ) and T 2 (r 2 ) relaxivity. The slope of the fitting line is the relaxivity.
Stability Analysis
The colloidal stability of the Au 15 NCs-DTPAA-Gd was estimated by UV-visible-NIR UV1800 spectrophotometry, 960PC spectrofluorometer and 3.0 T MR scanner. Au 15 NCs-DTPAA-Gd nanohybrids were incubated in phosphatebuffered saline (PBS) for a period of time (0 d 
Cell Uptake
Intracellular uptake of Au 15 NCs-DTPAA-Gd was measured in HepG2 cells and 293T cells. Cells were grown on 14 mm glass coverslips and allowed to adhere for 24 h. After coincubation with 10 mg/mL Au 15 NCs-DTPAA-Gd for different times, the cells were washed with PBS sufficiently to remove excess nanoclusters and fixed with 4% paraformaldehyde, and nuclei of the cells were stained with 4ʹ-6-diamidino-2-phenylindole (DAPI, 1 mg/mL in PBS, invitrogen). DAPI emission was recorded between 440 and 470 nm, Au 15 NCs-DTPAA-Gd emission images were obtained using a 630 nm longpass filter. Confocal fluorescence imaging studies were performed with confocal laser scanning microscope (Olympus FV10i, Tokyo, Japan).
In vivo CT/NIRF/MR Imaging
All animal experiments were carefully handled under the 
In vivo Pharmacokinetics and Biodistribution Analysis
For pharmacokinetic study, BALB/c mice were administered 150 μL of Au 15 NCs-DTPAA-Gd via tail vein. Blood samples were collected from eye socket at indicated time points (5 min, 10 min, 15 min, 20 min, 30 min, 1 h, 2 h, 4 h, 6 h), followed by weighing and dissolution in digestive chloroazotic acid (V HCl /V HNO3 = 1/3) to quantify the amount of Au and Gd via ICP-MS. Two-compartment pharmacokinetic model analysis of the data was performed with originpro software, and the pharmacokinetic parameters (e.g. elimination half-life, T 1/2 ) were calculated from the Gd contents in blood. For biodistribution analysis, mice were sacrificed after 10 mins, 30 mins, 2 hrs and 24 hrs post-injection, and major organs (heart, liver, spleen, lung, kidney) were extracted and digested in aqua regia (6 mL) overnight. Solutions were then diluted to 10 mL with deionized water. Finally, Au and Gd contents in each organ were analyzed by ICP-MS. Results were expressed as the percentage of the injected dose g −1 (%ID/g). All experiments were repeated three times.
In vivo Biocompatibility Evaluation
Biocompatibility of Au 15 NCs-DTPAA-Gd in vivo was evaluated by tissue Hematoxylin and eosin (H&E) staining. At 24 h and 2 weeks after injection with Au 15 NCs-DTPAA-Gd, the mice were sacrificed under anesthetic conditions. Tissues of interest (heart, liver, spleen, lung, and kidney) were excised and preserved in a 10% formalin solution for 2 weeks. Then, the formalin fixed tissues from each organ were embedded into paraffin and sectioned into 4 mm thickness. Each histological section was documented by a dissecting microscope. The tissues were sectioned into 4-mm thickness. Each histological section was documented by a dissecting microscope. The histological assessment was done with the help of the pathologist. Six mice injected with Au 15 NCs-DTPAA-Gd served as experimental group. We chose three tissue slices from each organ to perform H&E staining experiments.
Results and Discussion
Synthesis and Characterization of Au 15 NCs-DTPAA-Gd
In our study, the Au 15 NCs were synthesized by a one-step reduction method according to our previous optimized protocol. 26 Fifteen gold atoms form stable Au 15 NCs with glutathione via a strong thiolate-Au interaction. Au 15 NCs-DTPAA-Gd were synthesized via a classical amide reaction (Scheme 1). As determined by TEM ( Figure 1A) , the monodispersed spherical Au 15 NCs have a mean diameter of less than 1.0 nm. After conjugation with DTPAA-Gd, the well-dispersed Au 15 NCs-DTPAA-Gd nanohybrids remain a spherical shape and an average size of approximately 1.0 ± 0.4 nm with no significant change, as shown in Figure 1B . Elemental analysis by the corresponding EDS spectrum confirmed the composition and atomic distribution of the synthetic nanohybrids. The spectra and mapping of Figure 1B) and that of Au 15 NCs-DTPAA-Gd is 2.5 ± 0.4 nm ( Figure 1C ). The hydrodynamic diameter is slightly larger than that observed with TEM, which results from the hydration of rGSH and DTPAA-Gd in water. Figure 1E displays the UV-visible-NIR absorption spectra and emission spectra of Au 15 NCs and Au 15 NCs-DTPAA-Gd. A typical absorption spectrum of Au 15 NCs with distinct peaks at 370/410 nm is plotted in black solid line which is consistent with the reported literature. 27 Unlike the most popular and well-known spherical, large gold nanoparticles (AuNPs), AuNCs do not exhibit surface plasmon resonance (SPR) absorption in the visible region. 16, 28, 29 It is apparent that the absorption band of Au 15 NCs-DTPAA-Gd is similar to that of Au 15 NCs. It can be speculated that the introduction of DTPAA-Gd has no obvious effect on the Au 15 NCs, and no AuNPs are formed to stimulate surface plasmon resonance under these conditions. By fluorescence spectrophotometry, the emission spectra of Au 15 NCs-DTPAA-Gd and Au 15 NCs are similar with range of 550-800 nm peaking at 680 nm, suggesting their deep tissue penetration ability. The quantum yields of Au 15 NCs and Au 15 NCs-DTPAA-Gd were measured to be 7.8% and 7.6% at λ ex 470 nm, respectively. 15, 29, 30 The zeta potentials of Au 15 NCs and Au 15 NCs-DTPAA-Gd are about −5 mV and −24 mV, respectively ( Figure 1F ). The carboxylic groups of rGSH and DTPAA on the surface of the Au 15 NCs may cause Au 15 NCs and Au 15 NCs-DTPAA-Gd to be negatively charged. These results indicate Gd functionalization of Au 15 NCs by amide reaction is feasible.
In vitro CT/NIRF/MR Imaging
The synthesized Au 15 NCs-DTPAA-Gd possess excellent three model imaging properties. Owing to the higher atomic numbers and electron densities (79, 19.32 g/cm 3 ) of gold element than that of iodine (53, 4.93 g/cm 3 ), the attenuation intensity of Au 15 NCs-DTPAA-Gd was thus measured to assess the feasibility of their application as CT contrast agent. The CT images of Au 15 NCs-DTPAA-Gd nanohybrids at various concentration levels in Figure 2A indicate an obvious increase of the brightness with the increase of the hybrid concentration. Quantitative calculation ( Figure 2B ) confirms a linear relationship between the attenuation intensity and the content of Au in the nanohybrids. What is particularly remarkable is that there is almost twofold amplified attenuation intensity of Au 15 NCs-DTPAAGd compared with Omnipaque at equivalent concentration (I or Au). It is additionally demonstrated that the attenuation intensity of Au 15 NCs-DTPAA-Gd is higher than that of Au 15 NCs at the same Au concentrations. The phenomenon may be attributed to the existence of Gd ions possessing the relatively high atomic number and electron densities (64, 7.895 g/cm 3 ), 31 which results in synergistic enhancement of CT imaging capability. These observations well illustrate that the prepared Au 15 NCs-DTPAA-Gd provide a promising contrast agent for CT imaging.
The photographs in Figure 3A and B display that the brown solution of Au 15 NCs and Au 15 NCs-DTPAA-Gd (room light) emitted similar intense-red fluorescence under UV light (365 nm). As NIRF imaging agents, Au 15 NCs show strong quantum confinement effects and molecule-like properties while avoiding the photobleaching problems of conventional organic dyes. As shown in Figure 3C , both Au 15 NCs and Au 15 NCs-DTPAA-Gd nanohybrids exhibit similarly obvious enhancement of the NIRF signal with an increase of Au concentration. Moreover, the introduction of an additional functional DTPAA-Gd makes no effect on fluorescence property of Au 15 NCs. DTPAA is directly connected to glutathione on the surface of Au 15 NCs via an amide bond, which does not cause glutathione to detach significantly from the surface of gold. Therefore, the surface function of Au 15 NCs is not affected greatly. Meanwhile, the introduction of DTPAAGd did not significantly increase the size of Au 15 NCs. These factors may lead to no significant change in the fluorescence of Au 15 NCs-DTPAA-Gd compared with that of Au 15 NCs. It is known that Gd 3+ is able to induce the longitudinal relaxation of water protons, shorten the longitudinal relaxation time (T 1 ) and enhance MR imaging effect. 32 In the present case, T 1 and T 2 values of Au 15 NCs-DTPAA-Gd nanohybrids at various concentrations in aqueous medium were measured to estimate the longitudinal (r 1 ) and transverse (r 2 ) relaxivity. A dose-dependent brightening effect is observed in T 1 -weighted MR imaging ( Figure 4A ), r 1 and r 2 were calculated to be 8.5 and 9.6 mM −1 s −1 (with an r 2 /r 1 ratio of 1.13) (Figure 4C ), respectively. Importantly, MR signal intensity of Au 15 NCs-DTPAA-Gd is much stronger than that of Magnevist ( Figure 4A and B) , and the r 1 of Au 15 NCs-DTPAA-Gd exhibits about two times than that of Magnevist (3.97 mM
). Due to fifteen Gd-chelates formed on the surface of Au 15 NCs, it may be speculated that possible explanations for relatively higher r 1 value and MR signal of Au 15 NCs-DTPAA-Gd compared to Magnevist include: (i) an increase in rotational correlation time by virtue of the attachment of the metal chelate to macromolecules, (ii) an increase in the number of outer sphere-coordinated water molecules entrapped by the Au 15 NCs@GSH, and (ⅲ) the cooperative induction effect by the surface gadolinium in Au 15 NCs-DTPAA-Gd. 33, 34 This indicates a promising potential for utilizing Au 15 NCs-DTPAA-Gd nanohybrids as a superior T 1 -weighted MR imaging contrast agent.
Stability Analysis and Cytotoxicity
For further biomedical applications of Au 15 NCs-DTPAA-Gd, it is necessary to check stability in bio-fluids. The colloidal stability of Au 15 NCs-DTPAA-Gd dissolved in PBS was monitored constantly at different storage time points. In vitro MRI Au 15 NCs-DTPAA-Gd ( Figure 5A ) shows no significant 
Cell Uptake Studies
In this work, we want to initially explore the potential of Au 15 NCs-DTPAA-Gd as multimodal imaging probe of tumors, so the affinity of Au 15 NCs-DTPAA-Gd to tumor cells is of vital significance. The in vitro intake of Au 15 NCs-DTPAA-Gd by HepG2 and 293T cells was monitored with confocal fluorescence microscopy. As illustrated in Figure 6 , when HepG2 cells were incubated with Au 15 NCs-DTPAA-Gd for 24 h, obvious-red fluorescence was observed and mainly existed around the nucleus at 405 nm excitation. Compared with HepG2 cells, 293T cells incubated with Au 15 NCs-DTPAA-Gd for 24 h did not exhibit significant fluorescence. These results illustrated Au 15 NCs-DTPAA-Gd may efficiently enter cytoplasm through endocytosis of active cancer cells.
In vivo CT/NIRF/MR Imaging
The feasibility of Au 15 NCs-DTPAA-Gd as in vivo CT/NIRF/ MR trimodal imaging agent was exploited on BALB/c mice. Firstly, the accumulation of Au 15 NCs-DTPAA-Gd in liver makes this region brighter in CT image after 5-min injection with respect to that observed without administration (Figure 7Aa) . The X-ray attenuation intensities in the liver region before and after Au 15 NCs-DTPAA-Gd administration were quantitatively calculated to be 64.7 ± 2.2 HU and 120.5 ± 3.4 HU, respectively. After 10-min injection, both kidneys become clearer and brighter than those observed without administration (Figure 7Ab ). In the following, NIRF imaging was performed by intravenous administration of Au 15 NCs-DTPAA-Gd. Figure 7B illustrates an obvious enhancement on the fluorescence signal in mice liver after a 5-min injection. It is seen that obvious signal is observed in bladder at 20-min post-injection, indicating that Au 15 NCs-DTPAA-Gd is mainly eliminated via urinary route. Subsequently, T 1 -weighted MR images of mice were acquired before and after administering medication. It is seen that the liver is brightened after a 5-min injection (Figure 7Cc ). In addition, T 1 -weighted MRI and MIP images of cardiovascular (Figure 7Cc-d) after a 5-min injection were acquired. It is clearly observed that the cardiovascular function of the mice was significantly enhanced after injection. As shown in Figure 7Ce , both kidneys are brightened after 10-min injection, which are consistent with that observed in CT. Figure 7Cf shows that the bilateral renal pelvis is clear after 30-min injection. These observations suggest that the present Au 15 NCs-DTPAA-Gd platform exhibits favorable CT/NIRF/MR imaging capability in vivo.
In vivo Pharmacokinetics and Biodistribution Analysis
To explore the pharmacokinetic and biodistribution of Au 15 NCs-DTPAA-Gd, element gold and Gd of blood and organs were proceeded after injection of Au 15 NCs-DTPAA-Gd. As seen in Figure S3A , blood circulation behavior of Au 15 NCs-DTPAA-Gd is excellently conformed to two-compartment pharmacokinetics with blood elimination half-life (T 1/2 ) of 24.9 ± 0.5 min. The ideally longer elimination half-life compared to Omnipaque and Magnevist might aid to imaging and minimizing organ damage. The biodistribution of Au 15 NCs-DTPAA-Gd based on ICP-MS ( Figure S3B) 
In vivo Biocompatibility Evaluation
The in vivo toxicity of Au 15 NCs-DTPAA-Gd was evaluated by monitoring the pathological changes of several major organs of all mice using H&E staining sections. As shown in Figure 8 , compared to the control mice treated with PBS, the injection of the Au 15 NCs-DTPAA-Gd seems not to induce any noticeable changes in the morphology and other lesions (such as necrosis and inflammatory) of the organ sections from all mice. These results imply that Au 15 NCs-DTPAA-Gd possess good biocompatibility for applications.
Conclusions
In this work, a facile approach is developed for the configuration of multimodal imaging synergistical imaging nanohybrids (Au 15 NCs-DTPAA-Gd). Compared with conventional multimodal nanoplatform usually requiring a complicated synthetic procedure, Au 15 NCs-DTPAA-Gd nanohybrids have the potential to overcome the limitations of interference between imaging elements. The nanohybrids are highly water-dispersible, biocompatible and stable, which can not only realize CT/MRI collaborative imaging, but also exhibit photoluminescent capability in NIR region. Under the condition of meeting the needs of diagnosis, the Au 15 NCs-DTPAA-Gd with a lower dose than traditional contrast agents can reduce the toxicity of contrast agents as much as possible. Overall, the developed Au 15 NCs-DTPAA-Gd nanoplatform provides an efficient candidate as an imaging contrast agent for disease diagnosis, especially for early accurate detection of tumors.
